BioWorld

May 26, 2009

View Archived Issues

JNJ Captures Cougar in $970M Purchase

Johnson & Johnson went a long way toward strengthening its oncology pipeline, agreeing to buy Cougar Biotechnology Inc. in a deal worth just under $1 billion. (BioWorld Today) Read More

Patient Death Halts Aastrom's Cardiac Cell Therapy Study

Read More

HHS Directing $1B for H1N1 Swine Flu Vaccine

Read More

BIO Meeting 'Not Downbeat' Despite Economy, Politicking

Read More

Holiday Notice

Read More

Financings Roundup

Read More

Appointments And Advancements

Read More

Other News To Note

Read More